CN104958235A - 一种缓解眼疲劳黑眼圈的中药眼膜及其制备方法 - Google Patents
一种缓解眼疲劳黑眼圈的中药眼膜及其制备方法 Download PDFInfo
- Publication number
- CN104958235A CN104958235A CN201510409242.0A CN201510409242A CN104958235A CN 104958235 A CN104958235 A CN 104958235A CN 201510409242 A CN201510409242 A CN 201510409242A CN 104958235 A CN104958235 A CN 104958235A
- Authority
- CN
- China
- Prior art keywords
- parts
- eye mask
- chinese medicine
- blood
- black
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 98
- 208000003464 asthenopia Diseases 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims description 17
- 239000004863 Frankincense Substances 0.000 claims abstract description 18
- 210000000582 semen Anatomy 0.000 claims abstract description 18
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000002673 Dioscorea communis Nutrition 0.000 claims description 31
- 241000544230 Dioscorea communis Species 0.000 claims description 31
- 208000035753 Periorbital contusion Diseases 0.000 claims description 31
- 229940079593 drug Drugs 0.000 claims description 31
- 230000008901 benefit Effects 0.000 claims description 20
- 241001057584 Myrrha Species 0.000 claims description 19
- 241000717739 Boswellia sacra Species 0.000 claims description 17
- 241000628997 Flos Species 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 241000180649 Panax notoginseng Species 0.000 claims description 13
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 13
- 239000000706 filtrate Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 10
- 210000001015 abdomen Anatomy 0.000 claims description 9
- 238000004821 distillation Methods 0.000 claims description 9
- 238000004659 sterilization and disinfection Methods 0.000 claims description 9
- 230000001954 sterilising effect Effects 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- 238000002425 crystallisation Methods 0.000 claims description 7
- 230000008025 crystallization Effects 0.000 claims description 7
- 238000010298 pulverizing process Methods 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000000108 ultra-filtration Methods 0.000 claims description 6
- 238000002481 ethanol extraction Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000004321 preservation Methods 0.000 claims description 5
- 239000003755 preservative agent Substances 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 4
- 230000002829 reductive effect Effects 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 230000002421 anti-septic effect Effects 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 235000011837 pasties Nutrition 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 239000013078 crystal Substances 0.000 claims description 2
- 238000010410 dusting Methods 0.000 claims description 2
- 230000008719 thickening Effects 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims 2
- 239000008280 blood Substances 0.000 abstract description 120
- 210000004369 blood Anatomy 0.000 abstract description 111
- 230000000694 effects Effects 0.000 abstract description 29
- 230000008961 swelling Effects 0.000 abstract description 17
- 241000475481 Nebula Species 0.000 abstract description 8
- 239000000463 material Substances 0.000 abstract description 8
- 230000000144 pharmacologic effect Effects 0.000 abstract description 8
- 230000003213 activating effect Effects 0.000 abstract description 6
- 235000013399 edible fruits Nutrition 0.000 abstract description 5
- 208000003351 Melanosis Diseases 0.000 abstract description 4
- 244000131316 Panax pseudoginseng Species 0.000 abstract description 4
- 230000004089 microcirculation Effects 0.000 abstract description 4
- 238000011160 research Methods 0.000 abstract description 4
- 240000007311 Commiphora myrrha Species 0.000 abstract description 3
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract description 3
- 244000020518 Carthamus tinctorius Species 0.000 abstract description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract description 2
- 244000111489 Gardenia augusta Species 0.000 abstract description 2
- 235000018958 Gardenia augusta Nutrition 0.000 abstract description 2
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract description 2
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract description 2
- 210000004204 blood vessel Anatomy 0.000 abstract description 2
- 230000000916 dilatatory effect Effects 0.000 abstract description 2
- 230000002093 peripheral effect Effects 0.000 abstract description 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241001313857 Bletilla striata Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 241000167550 Centella Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 206010014970 Ephelides Diseases 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 244000179560 Prunella vulgaris Species 0.000 abstract 1
- 244000151637 Sambucus canadensis Species 0.000 abstract 1
- 235000018735 Sambucus canadensis Nutrition 0.000 abstract 1
- 240000006688 Telosma cordata Species 0.000 abstract 1
- 235000017352 Telosma cordata Nutrition 0.000 abstract 1
- 235000007123 blue elder Nutrition 0.000 abstract 1
- 235000007124 elderberry Nutrition 0.000 abstract 1
- 235000008995 european elder Nutrition 0.000 abstract 1
- 208000000069 hyperpigmentation Diseases 0.000 abstract 1
- 230000003810 hyperpigmentation Effects 0.000 abstract 1
- 235000008113 selfheal Nutrition 0.000 abstract 1
- 238000010792 warming Methods 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 56
- 208000002193 Pain Diseases 0.000 description 37
- 230000036407 pain Effects 0.000 description 35
- 238000011282 treatment Methods 0.000 description 32
- 230000017531 blood circulation Effects 0.000 description 29
- 210000003734 kidney Anatomy 0.000 description 23
- 230000001737 promoting effect Effects 0.000 description 22
- 230000004438 eyesight Effects 0.000 description 17
- 201000010099 disease Diseases 0.000 description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 16
- 210000003462 vein Anatomy 0.000 description 15
- 231100000614 poison Toxicity 0.000 description 11
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 10
- 241000700199 Cavia porcellus Species 0.000 description 10
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 10
- 206010013935 Dysmenorrhoea Diseases 0.000 description 10
- 206010030113 Oedema Diseases 0.000 description 10
- 206010015150 Erythema Diseases 0.000 description 9
- 206010007247 Carbuncle Diseases 0.000 description 8
- 208000005171 Dysmenorrhea Diseases 0.000 description 8
- 208000019255 Menstrual disease Diseases 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 8
- 210000000481 breast Anatomy 0.000 description 8
- 230000001717 pathogenic effect Effects 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 208000006820 Arthralgia Diseases 0.000 description 7
- 206010019233 Headaches Diseases 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 231100000869 headache Toxicity 0.000 description 7
- 208000014674 injury Diseases 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- 239000013641 positive control Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 201000000736 Amenorrhea Diseases 0.000 description 6
- 206010001928 Amenorrhoea Diseases 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 6
- 231100000540 amenorrhea Toxicity 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 230000001684 chronic effect Effects 0.000 description 6
- 230000004087 circulation Effects 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 210000000214 mouth Anatomy 0.000 description 6
- 239000002574 poison Substances 0.000 description 6
- 230000008736 traumatic injury Effects 0.000 description 6
- 239000011800 void material Substances 0.000 description 6
- 206010054196 Affect lability Diseases 0.000 description 5
- 206010021143 Hypoxia Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 206010027514 Metrorrhagia Diseases 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- 208000025747 Rheumatic disease Diseases 0.000 description 5
- 238000009825 accumulation Methods 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 229910002092 carbon dioxide Inorganic materials 0.000 description 5
- 239000001569 carbon dioxide Substances 0.000 description 5
- 230000001276 controlling effect Effects 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 210000003743 erythrocyte Anatomy 0.000 description 5
- 230000011512 eye pigmentation Effects 0.000 description 5
- 230000007954 hypoxia Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000002398 materia medica Substances 0.000 description 5
- 230000002503 metabolic effect Effects 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 239000000049 pigment Substances 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 230000000552 rheumatic effect Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 239000002699 waste material Substances 0.000 description 5
- 230000002087 whitening effect Effects 0.000 description 5
- 208000004998 Abdominal Pain Diseases 0.000 description 4
- 244000025254 Cannabis sativa Species 0.000 description 4
- 206010010726 Conjunctival oedema Diseases 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 4
- 208000015220 Febrile disease Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000002951 depilatory effect Effects 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 230000002175 menstrual effect Effects 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 206010040872 skin infection Diseases 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 240000006409 Acacia auriculiformis Species 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 241000447727 Scabies Species 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000035617 depilation Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 210000005069 ears Anatomy 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 208000005687 scabies Diseases 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 201000004384 Alopecia Diseases 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 208000012639 Balance disease Diseases 0.000 description 2
- 208000010392 Bone Fractures Diseases 0.000 description 2
- 206010007882 Cellulitis Diseases 0.000 description 2
- 208000034656 Contusions Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010020565 Hyperaemia Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 241000590428 Panacea Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 208000004680 Rectal Fistula Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000032023 Signs and Symptoms Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 229930003448 Vitamin K Natural products 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 231100000360 alopecia Toxicity 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 206010002156 anal fistula Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 208000034526 bruise Diseases 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 230000000881 depressing effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 231100000880 dysequilibrium Toxicity 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 229960004756 ethanol Drugs 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 230000002443 hepatoprotective effect Effects 0.000 description 2
- 230000003118 histopathologic effect Effects 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 230000008338 local blood flow Effects 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000007102 metabolic function Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 206010034754 petechiae Diseases 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 238000004080 punching Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000000452 restraining effect Effects 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000015096 spirit Nutrition 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 229940046010 vitamin k Drugs 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000003910 Baronia <angiosperm> Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 101100285402 Danio rerio eng1a gene Proteins 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000909851 Epiphora Species 0.000 description 1
- 241000195952 Equisetaceae Species 0.000 description 1
- 244000085625 Equisetum Species 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 244000283207 Indigofera tinctoria Species 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 206010024728 Lividity Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 241000607292 Maguireothamnus speciosus Species 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010027146 Melanoderma Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010054107 Nodule Diseases 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 208000025174 PANDAS Diseases 0.000 description 1
- 208000021155 Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection Diseases 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 240000000220 Panda oleosa Species 0.000 description 1
- 235000016496 Panda oleosa Nutrition 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 206010068676 Pneumoretroperitoneum Diseases 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 201000002154 Pterygium Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 208000029091 Refraction disease Diseases 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- 208000005727 Retropneumoperitoneum Diseases 0.000 description 1
- 241001050737 Sambucus williamsii Species 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 206010040849 Skin fissures Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010061577 Ulcer haemorrhage Diseases 0.000 description 1
- 241000934136 Verruca Species 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000004430 ametropia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 201000009310 astigmatism Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000009267 bronchiectasis Diseases 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 208000016747 lacrimal apparatus disease Diseases 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000032630 lymph circulation Effects 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- XRRQZKOZJFDXON-UHFFFAOYSA-N nitric acid;silver Chemical compound [Ag].O[N+]([O-])=O XRRQZKOZJFDXON-UHFFFAOYSA-N 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 208000018299 prostration Diseases 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 208000014733 refractive error Diseases 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000008326 skin blood flow Effects 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 210000000264 venule Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000002918 waste heat Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000009306 yunnan baiyao Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种缓解眼疲劳、黑眼圈的中药眼膜,所述中药眼膜中各种原料药的重量份数包括:木贼10~20份,当归10~20份,川芎10~20份,没药10~20份,丹参10~20份,决明子10~20份,三七10~20份,石决明10~20份,红花10~20份,白芍10~20份,白芨10~20份,薄荷10~20份,夏枯草10~20份,紫花地丁10~20份,白芷10~20份,乳香10~20份,鸡血藤10~20份,栀子10~20份,接骨木10~20份。本发明根据传统中医理论及现代药理研究结果,反复筛选外用药,配制成中药眼膜,具有温通血脉,活肤化瘀,养血祛斑,明目退翳、消肿祛瘀,润泽肌肤的功效。能有效扩张末梢血管,改善面部微循环,对眼周色素沉着有一定的改善作用。
Description
技术领域
本发明涉及含有来源于植物、动物或矿物组份的美容配制品,特别涉及一种缓解眼疲劳、黑眼圈的中药眼膜及其制备方法。
背景技术
随着社会的进步,脑力劳动者增多,上班用电脑,长期手机不离手,熬夜打游戏的年轻人越来越多。长期不正确的用眼习惯而造成用眼过度,是眼睛疲劳的一大主因。眼睛疲劳的一般症状是视物稍久则模糊,有的甚至无法写作或阅读,眼睛干涩、头昏痛,严重时可出现恶心、呕吐等。另外,视疲劳还有可能会导致成年人发生近视、散光等屈光不正问题,除此之外,其它一些眼疾问题也有可能会伴随着用眼过度而来。
保护眼睛、防止视力伤害、减缓眼疲劳,除了光线适宜、保持正确的操作姿势、保证休息和做眼保健操之外,还有一条非常重要,那就是要给眼睛补充营养。
现代医学研究表明,维生素与眼疾的发生、视力的好坏有着非常密切的关系。用眼过多者,需要更多的眼睛所需的维生素及矿物质。合理补充眼睛所需的营养素,对保护眼睛、防止视力伤害、防治眼疾、提高视力非常重要。
黑眼圈是由于经常熬夜,情绪不稳定,眼部疲劳、衰老,静脉血管血流速度过于缓慢,眼部皮肤红血球细胞供氧不足,静脉血管中二氧化碳及代谢废物积累过多,形成慢性缺氧,血液较暗并形成滞流以及造成眼部色素沉着。黑眼圈也是我们常说的“熊猫眼”,是由于经常熬夜,情绪不稳定,眼部疲劳、衰老,静脉血管血流速度过于缓慢,眼部皮肤红血球细胞供氧不足,静脉血管中二氧化碳及代谢废物积累过多,形成慢性缺氧,血液较暗并形成滞流以及造成眼部色素沉着。
年纪愈大的人,眼睛周围的皮下脂肪变得愈薄,所以黑眼圈就更明显。黑眼圈其实分两种颜色,一种是青色黑眼圈,这是因为微血管的静脉血液滞留;另一种是茶色黑眼圈,因黑色素生成与代谢不全而产生,两种黑眼圈产生的原因完全不同。青黑色眼圈通常发生在20岁左右,生活作息不正常的人尤难避免。现在由于学生学习压力较大,年轻人熬夜已经成为家常便饭,所以出现黑眼圈的人群的年龄有下移的趋势,18岁以上的人群里黑眼圈就已经很普遍。因其微血管内血液流速缓慢,血液量增多而氧气消耗量提高,缺氧血红素大增的结果。从外表看来,皮肤就出现暗蓝色调。由于眼睛周围较多微血管,因此睡眠不足、眼睛疲劳、压力、贫血等因素,都会造成眼周肌肤淤血及浮肿现象。茶黑色眼圈的成因则和年龄增长息息相关,长期日晒造成色素沉淀在眼周,久而久之就会形成挥之不去的黑眼圈;
由于眼周皮肤是人体最敏感最娇嫩的所在,又受到许多外界的因素如日晒、电脑幅射、手机辐射、接触光敏性药物或化合物、高强度用眼等的影响,因此一般主张内外治结合。并且由于眼周皮肤很敏感,因此外治的方法成为本病治疗中的一个关键的方面。
黑眼圈形成后应对症下药,请教医生,找出病因,及时治疗;对于精神抑郁形黑眼圈要保持精神愉快,减少精神负担,生活有规律,节制烟酒,保障充足的睡眠,促使气血旺盛,容颜焕发;加强眼部的按摩,改善局部血液循环状态,减少淤血滞留;对于遗传性难治的黑眼圈应以保持眼部皮肤的营养供应为主,如涂含油分、水分充足的眼霜,使眼部皮肤及皮下组织充满活力,淡化黑眼圈。
中医理论认为大部分黑眼圈的发生与肝肾虚有关,肝肾虚后,肾精不能养肝血,而“肝开窍于目”,最终因精血亏损,表现在双眼上就形成黑眼圈。而现代研究也证实黑眼圈是由于经常熬夜,情绪不稳定,眼部疲劳、衰老,导致静脉血管血流速度过于缓慢,眼部皮肤红血球细胞供氧不足,静脉血管中二氧化碳及代谢废物积累过多,形成慢性缺氧,血液较暗并形成滞留以及造成眼部色素沉着,这与中医理论是相吻合的。对于黑眼圈,传统上可以考虑化学换肤或擦退色素药膏,但效果并不十分明显,但是这几年来,激光去黑眼圈大大增多。激光能改善皮肤的新陈代谢,促进血液的循环、淋巴循环,使深深的眼袋的色素慢慢的淡化,大约一个疗程以后就会看到明显的激光美容去黑眼圈的效果。激光去黑眼圈是属于无创美容的,不需要麻醉,激光去黑眼圈在进行治疗后会个别的有局部红肿的现象,这属于正常的现象,如果配合好眼部周围的护理和日常的保养,效果会更加的持久,激光去黑眼圈的技术具有无开放性的损伤,无需麻醉,非常安全的优点。个别女性的黑眼圈在术后会有局部的红肿,不过这属于正常的,若做好护理和保养效果会比较持久。但价格昂贵,不是每个人都能负担的起。
发明内容
本发明所要解决的技术问题在于,有关眼疲劳、黑眼圈的缓解,临床激光虽有一定疗效,但价格昂贵,有不同程度的副作用或引起某些并发症;而中药制品则因其取材天然、安全性好、低副作用、文献资料丰富、临床疗效佳而备受青睐。但现有的方剂针对性差,不能从根本上缓解眼疲劳和黑眼圈,并且还有一定的副作用。因此,寻找一种高效安全的中药眼膜成为人们的迫切需求。
为解决这些技术难题,本发明提供了一种缓解眼疲劳、黑眼圈的中药眼膜,其所述中药眼膜中各种原料药的重量份数为:木贼10~20份,当归10~20份,川芎10~20份,没药10~20份,丹参10~20份,决明子10~20份,三七10~20份,石决明10~20份,红花10~20份,白芍10~20份,白芨10~20份,薄荷10~20份,夏枯草10~20份,紫花地丁10~20份,白芷10~20份,乳香10~20份,鸡血藤10~20份,栀子10~20份,接骨木10~20份。
所述缓解眼疲劳、黑眼圈的中药眼膜,其所述中药眼膜中各种原料药的重量份数可以为:木贼10~15份,当归10~15份,川芎10~15份,没药10~15份,丹参10~15份,决明子10~15份,三七10~15份,石决明10~15份,红花10~15份,白芍10~15份,白芨10~20份,薄荷10~20份,夏枯草10~20份,紫花地丁10~20份,白芷10~20份,乳香10~20份,鸡血藤10~20份,栀子10~20份,接骨木10~20份。
所述缓解眼疲劳、黑眼圈的中药眼膜,其所述中药眼膜中各种原料药的重量份数还可以为:木贼10~20份,当归10~20份,川芎10~20份,没药10~20份,丹参10~20份,决明子10~20份,三七10~20份,绞股蓝10~20份,红花10~20份,白芍10~20份,白芨10~15份,薄荷10~15份,夏枯草10~15份,紫花地丁10~15份,白芷10~20份,乳香10~20份,鸡血藤10~20份,栀子10~20份,接骨木10~20份。
为解决上述技术问题,本发明还提供一种缓解眼疲劳,黑眼圈的中药眼膜的制备方法,其所述制备步骤包括:
a、取薄荷、没药、乳香和白芨用蒸馏法汽化成结晶,粉碎待用,为组分1;
b、其他原料加乙醇提取2次,浓缩过滤为膏状,为组分2;
c、将上述两种组分合并,消毒后加防腐剂调成糊状眼膜。
所述步骤a中,可以先将原料药薄荷、没药、乳香和白芨用水蒸气法蒸馏,得到结晶物,然后粉碎,过100-120目筛,作为组分1备用。
所述步骤b中,可以取其他原料药加入5-10倍量的乙醇中浸泡4-6小时,加热提取2次,每次1-2小时,合并提取液,静置后去上清液,然后100-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.36的浸膏,静置备用,成为组分2。
所述步骤c中,可以将蒸馏提取的组分1和乙醇提取的组分2混合,加防腐剂调成眼膜,用紫外线杀菌后装瓶。
为解决上述技术问题,本发明再提供一种缓解眼疲劳,黑眼圈的中药眼膜的制备方法,所述制备方法包括:
取薄荷、没药、乳香和白芨用蒸馏法汽化成结晶,粉碎过细筛后待用,为组分1;将其余原料药粉碎成颗粒,加水浸泡2-3小时;将浸泡好的原料药置于多功能提取罐中,加水煎煮二次;第一次加总药量质量的10倍量的水,煎煮1~2小时,取煎液,滤过;第二次加加总药量质量7倍量的水,煎煮1~1.5小时,取两次煎液混合,过滤;将过滤的滤液置入双效真空浓缩器中浓缩冷藏,成组分2;然后混合组分1与组分2,调和防腐剂紫外线杀菌后装瓶。
滤液在双效真空浓缩器中浓缩的步骤为:先将滤液浓缩至80℃时相对密度为1.25的浓缩液,置0~5℃低温冷藏24小时;将冷藏液加0.3%的助滤剂硅藻土,过滤,滤液再置入双效真空浓缩器中,浓缩至每1ml含0.1g生药量,成组分2。
所述缓解眼疲劳,黑眼圈的中药眼膜,其使用步骤是,洁面后,将眼膜均匀涂抹于眼周,并用中指指肚在眼周按摩15-30分钟,洗去即可;或用眼膜纸将眼膜涂抹范围盖住,第二天早起洗去即可。
本发明参考古今中医学药理研究成就,筛选补气活血、清肝明目、疏散风热、明目退翳、平肝潜阳、清热解毒、清热泻火的天然中药,扶正祛邪,通腑泄毒,活血散瘀,调节人体的新陈代谢机能,提高人体眼周皮肤血液循环,从而达到祛斑养颜、缓解疲劳、美化容貌的目的。本发明根据传统中医理论及现代药理研究结果,反复筛选外用药,配制成中药眼膜,具有疏散风热、明目退翳、温通血脉、活肤化瘀、养血祛斑、润泽肌肤的功效。能有效扩张末梢血管,改善面部眼周微循环,对色素沉着有一定的抑制作用。本发明治疗效果较理想,且无毒安全,制备方法简便易行,能创造良好的社会效益与经济效益。
具体实施方式
每个有和黑眼圈奋斗经历的人都会发现,黑眼圈是个异常顽固的敌人,日常保养和充足睡眠会让它减弱,但只要稍不留意,它就会又跑出来兴风作浪。其实黑眼圈再顽固,适合的眼霜和眼膜其实是能有效缓解黑眼圈的,关键是选对产品。毕竟松弛是由于年龄增长、胶原纤维减少、紫外线照射而引起弹性硬蛋白变性所产生的,所以,需要预防胶原纤维的减少和弹性硬蛋白的变性。重要的是,不光在眼周,在整个面部都要提高肌肉力量,保持肌肤弹性。能增加胶原纤维弹性的紧实型眼霜,是松弛型黑眼圈的最佳选择。
中医理论认为大部分黑眼圈的发生与肝肾虚有关,肝肾虚后,肾精不能养肝血,而“肝开窍于目”,最终因精血亏损,表现在双眼上就形成黑眼圈。而现代研究也证实黑眼圈是由于经常熬夜,情绪不稳定,眼部疲劳、衰老,导致静脉血管血流速度过于缓慢,眼部皮肤红血球细胞供氧不足,静脉血管中二氧化碳及代谢废物积累过多,形成慢性缺氧,血液较暗并形成滞留以及造成眼部色素沉着,这与中医理论是相吻合的。
祖国医学认为,本病发生的内因与肝、脾、肾三脏以及气血运行的失常关系密切,因此内治在脏腑多从肝脾肾论治,但也是身体内部平衡失调的外在反映。所以在治疗上要从整体出发,辨证施治。肝脾精血充盈、冲任调畅,则血络自有载药之资。肝主疏泄,能调达气血,舒畅情志。若肝气郁结则气血失和,气滞血瘀,壅滞络脉,上结于面则致面斑。肝主藏血。肝血充和,则体健面润。若肝肾不足,精血亏虚,不能上荣则易生面斑。
中医气血理论认为,气血循环过程是人体一切组织器官进行工作的物质基础,气血以流畅平衡为贵,如果气血不流畅就会产生瘀血,瘀血阻于体内,将进一步导致气血循环的恶化,造成更严重的瘀塞,故中医以气血为纲,通过调气活血使之流畅平衡,可祛病强身、养血美容。皮肤斑点之根本在瘀,退斑必先祛瘀、祛瘀当须活血,活血更须补气、理气,气为血之帅,血随之而运行;血为气之守,气得之而静谧,气结则血凝,气虚则血脱,气迫则血走。气血和则俱和。而理气在肝,补气在肺肾,肺主皮毛。因气滞血瘀,影响到肺脾肝肾的气血运行功能,而致面部出现黄褐斑、黑眼圈、雀斑等色斑,甚至出现头发脱落、斑秃。本发明主要根据传统中医学辨正施治的原理,集众医家所长,广采博收地区奇药妙方,提取精华;基于中医学对面部色斑的发病机理的认识及治疗原则,参考古今中医学药理研究成就,筛选补气活血、补气升阳、疏肝解郁、平肝潜阳、滋阴补肾、清热解毒、清热泻火的天然中药,扶正祛邪,通腑泄毒,活血散瘀,调节人体的新陈代谢机能,提高人体血液循环及肝脏解毒能力,并经长期诊疗病例的临床实践总结而成。
当归:其味甘而重,故专能补血,其气轻而辛,故又能行血,补中有动,行中有补,诚血中之气药,亦血中之圣药。大约佐之以补则补,故能养营养血,补气生精,安五脏,强形体,益神志,凡有形虚损之病,无所不宜。佐之以攻则通,故能祛痛通便,利筋骨,治拘挛、瘫痪、燥、涩等证。营虚而表不解者,佐以柴、葛、麻、桂等剂,大能散表卫热,而表不敛者,佐以大黄之类,又能固表。惟其气辛而动,故欲其静者当避之,性滑善行,大便不固者当避之。凡阴中火盛者,当归能动血,亦非所宜,阴中阳虚者,当归能养血,乃不可少。
川芎辛,温。归肝、胆、心包经。功能活血行气,祛风止痛。用于月经不调,经闭痛经,症瘕腹痛,胸胁刺痛,跌扑肿痛,头痛,风湿痹痛。川穹性温,是妇科常用药品,有活血顺气的作用,但也不能多用,尤其是身体有出血现象的人不适合服用,如女性经期。同时,川穹又是药膳中常用的药材之一,与乌鸡同食,可以养阴活血,是女性滋补佳品。
生地:生地也叫生地黄,玄参科多年生草本植物地黄Rehmannia glutinosaLibosch.的新鲜或干燥的块根。清热、生津、润燥、滑肠、破瘀、生新、止痛、调经、金疮瘀、凉血、止血;鲜地黄和生地黄的作用是有所不同的。鲜地黄清热生津,可以止血和凉血,经常是用于热病伤阴,吐血、咽喉肿痛、舌绛烦渴、发斑发疹以及衄热等病症。相对于鲜地黄,生地黄是凉血清热,也可以生津,还可以养阴,多用于治疗阴虚内热、骨蒸劳热、舌绛烦渴、发斑发疹等问题。生地性寒,功能为滋阴补肾。不只生津止渴和凉血清热,还对血崩、月经不调、胎动不安、便秘等有作用,凡是血分有热伤阴的人,都可以经常服用。如果想要治疗温热病,可以用生地做清营汤;如果是治疗温病的后期,由于余热还没消尽,应该把生地用来煮青蒿鳖甲汤;另外,针对血热毒盛,斑疹紫黑,温热病严重热入营血的症状,可以服用生地制成的四生丸;一般要养阴生津来治疗内热消渴和便秘的,应该食用生地煮的曾液汤
白芍入肝、脾经,养血柔肝,缓中止痛,敛阴收汗。治胸腹胁肋疼痛,泻痢腹痛,自汗盗汗,阴虚发热,月经不调,崩漏,带下,妇人血闭不通,消瘀血,能蚀脓,益女子血。《日华子本草》:治风、补劳,主女人一切病,并产前后诸疾,通月水,退热,除烦,益气,天行热疾,瘟瘴,惊狂,妇人血运,及肠风,泻血,痔瘘。发背,疮疥,头痛,明目,目赤努肉。赤色者多补气,白者治血。
白芨性苦、甘、涩,微寒。归肺、肝、胃经。功能主治收敛止血,消肿生肌。用于咳血吐血,外伤出血,疮疡肿毒,皮肤皲裂;肺结核咳血,溃疡病出血。《神农本草经》:“主痈肿、恶疮、败疽,伤阴死肌,胃中邪气”;《本草纲目》:“气味(根)苦、平、无毒。
白芷性味归经:辛,温。归肺、胃经。祛风散寒,通窍止痛,消肿排脓,燥湿止带。《日华子本草》:治目赤胬肉,及补胎漏滑落,破宿血,补新血,乳痈、发背、瘰疬、肠风、痔瘘,排脓,疮痍、疥癣,止痛生肌,去面皯疵瘢。
丹参苦,微寒。归心、肝经。祛瘀止痛,活血通经,清心除烦。用于月经不调,经闭痛经,症瘕积聚,胸腹刺痛,热痹疼痛,疮疡肿痛,心烦不眠。用于胸肋胁痛,风湿痹痛,症瘕结块,疮疡肿痛,跌仆伤痛,月经不调,经闭痛经,产后瘀痛等。治疗胸肋疼痛、症瘕结块,以及月经不调、经闭经痛具有良效。《纲目》载:丹参,按《妇人明理论》云,四物汤治妇人病,不问产前产后,经水多少,皆可通用,惟一味丹参散,主治与之相同。盖丹参能破宿血,补新血,安生胎,落死胎,止崩中滞下,调经脉。丹参主要成分丹参酮有扩张血管、改善循环、解除血管内凝血等作用,具有活血化痕之功效,并能促进肝脏血液循环,利于肝细胞再生。
鸡血藤性苦、甘,温。归肝、肾经,补血,活血,通络。用于月经不调,血虚萎黄,麻木瘫痪,风湿痹痛活血舒筋;养血调经,《本草纲目拾遗》载其能医手足麻木;肢体瘫痪;风湿痹痛;妇女有经不调;痛经。
薄荷,土名叫“银丹草”,为唇形科植物,即同属其他干燥全草,多生于山野湿地河旁,根茎横生地下,是一种有特种经济价值的芳香作物。全株青气芳香。叶对生,花小淡紫色,唇形,花后结暗紫棕色的小粒果。薄荷是中华常用中药之一。它是辛凉性发汗解热药,治流行性感冒、头疼、目赤、身热、咽喉、牙床肿痛等症。处用可治神经痛、皮肤瘙痒、皮疹和湿疹等。薄荷是中国常用中药,幼嫩茎尖可作菜食,全草又可入药,治感冒发热喉痛,头痛,目赤痛,肌肉疼痛,皮肤风疹搔痒,麻疹不透等症,此外对痈、疽、疥、癣、漆疮亦有效。薄荷含有薄荷醇,该物质可清新口气并具有多种药性,可缓解腹痛、胆囊问题如痉挛,还具有防腐杀菌、利尿、化痰、健胃和助消化等功效。大量食用薄荷可导致失眠,但小剂量食用却有助于睡眠。
没药(Commiphora myrrha Eng1.),又名末药,为橄榄科植物地丁树或哈地丁树的干燥树脂。主产于非洲索马里、埃塞俄比亚以及印度等地。采集由树皮裂缝处渗出的白色油胶树脂,于空气中变成红棕色而坚硬的圆块。打碎后,炒至焦黑色应用。主治胸腹瘀痛、痛经、经闭、症瘕、跌打损伤、痈肿疮疡、肠痈、目赤肿痛。有活血止痛、消肿生肌等功效。在东方是一种活血、化瘀、止痛、健胃的中药,湿寒性或黏液质性疾病,如湿寒性关节疼痛,坐骨神经痛,口腔疼痛,咽喉疼痛,寒性咳嗽,湿性痰多,支气管扩张,湿疹脓疮,月经不调,小便不利。《注医典》:“生发固发,祛斑消痕,软坚除瘤,除癣愈创,固齿健龈,解毒等。治脱发毛细,黑斑伤痕,扁平疣,各种湿疹,牙龈糜烂,毒虫叮伤等。”没药配伍红花没药活血止痛,红花活血祛淤通经。二者合用,有活血、祛淤、通经、止痛之功效,用於治疗血淤所致之心腹疼痛、痛经、产后淤阻腹痛及跌打损伤之淤滞疼痛。
乳香调气活血,定痛,追毒。治气血凝滞、心腹疼痛,痈疮肿毒,跌打损伤,痛经,产后瘀血刺痛。《别录》:疗风水毒肿,去恶气。疗风瘾疹痒毒。《本草拾遗》:疗耳聋,中风口噤,妇人血气,能发酒,理风冷,止大肠泄澼,疗诸疮令内消。《日华子本草》:止霍乱,心腹痛。煎膏止痛长肉。
木贼药用为木贼科植物木贼的全草,木贼(拉丁学名:Equisetum hyemaleL.)别称:千峰草、锉草、笔头草、笔筒草、接骨草、马人参等。木贼味甘、苦,性平。归肺、肝经,具有疏散风热、明目退翳、止血的功效。木贼夏季采收,除去杂质,晒干或阴干贮藏,药用炮制:除去枯茎及残根,喷淋清水,稍润,切段,干燥。切断段。疏风散热,解肌,退翳。治目生云翳,迎风流泪,肠风下血,血痢,脱肝,疟疾,喉痛,痈肿。《嘉祜本草》:主目疾,退翳膜。又消积块,益肝胆,明目,疗肠风,止痢及妇人月水不断。《纲目》:解肌,止泪,止血,去风湿,疝痛,大肠脱肛。
石决明石决明成寒清热,质重潜阳,专入肝经,而有平肝阳、清肝热之功,为凉肝、镇肝之要药。用治肝肾阴虚、肝阳眩晕症,常与生地黄、白芍药、牡蛎等养阴、平肝药物配伍;肝阳上亢、肝火亢盛、头晕头痛、烦躁易怒者,可与夏枯草、钩藤、夏枯草等清热、平肝药物同用。肝开窍於目,石决明清肝火而明目退翳,为治目疾之常用药。治疗肝火上炎、目赤肿痛,可与夏枯草、决明子、夏枯草等配伍;治疗风热目赤、翳膜遮睛,可与蝉蜕、夏枯草、木贼等配伍;阴虚血少之目暗不瞻、雀盲眼花者,每与熟地黄、枸杞子、菟丝子等配伍。
红花(拉丁学名:Carthamus tinctorius L.),别名:红蓝花、刺红花,菊科、红花属植物,干燥的管状花,橙红色,花管狭细,先端5裂,裂片狭线形,花药黄色,联合成管,高出裂片之外,其中央有柱头露出。具特异香气,味微苦。以花片长、色鲜红、质柔软者为佳。活血通经,散瘀止痛,有助于治经闭、痛经、恶露不行、胸痹心痛、瘀滞腹痛、胸胁刺痛、跌打损伤、疮疡肿痛疗效。有活血化瘀,散湿去肿的功效,
决明子,中药名。是豆科植物决明或小决明的干燥成熟种子,以其有明目之功而名之。秋季采收成熟果实,晒干,打下种子,除去杂质。决明子味苦、甘、成,性微寒,入肝、肾、大肠经;润肠通便,降脂明目,治疗便秘及高血脂,高血压。清肝明目,利水通便,有缓泻作用,降血压降血脂。
夏枯草可以清火明目,能治目赤肿痛、头痛等作用。其为清肝、护肝“圣药”。专治目珠夜痛、头目眩晕。清肝泻火,明目,散结消肿。用于目赤肿痛,目珠夜痛,头痛眩晕,瘰疬,瘿瘤,乳痈,乳癖,乳房胀痛。
紫花地丁味苦、辛、寒。归心、肺经。具有清热解毒,凉血消肿,清热利湿的作用,主治疔疮,痈肿,瘰疬,黄疸,痢疾,腹泻,目赤,喉痹,毒蛇咬伤。
三七是以其根部入药,其性温,味辛,具有显著的活血化瘀、消肿定痛功效,有“金不换”、“南国神草”之美誉。因常在春冬两季采挖,又分为“春七”和“冬七”。清朝药学著作《本草纲目拾遗》中记载:“人参补气第一,三七补血第一,味同而功亦等,故称人参三七,为中药中之最珍贵者。”扬名中外的中成药“云南白药”和“片仔癀”,即以三七为主要原料制成。主治咯血,吐血,衄血,便血,崩漏,外伤出血,胸腹刺痛,跌扑肿痛。
接骨木:拉丁学名Sambucus williamsii。甘、苦,平。祛风,利湿,活血,止痛。用于风湿筋骨痛,腰痛,水肿,风疹,瘾疹,产后血晕,跌打肿痛,骨折,创伤出血。根或根皮(接骨木根):甘,平。用于风湿关节痛,痰饮,水肿,泄泻,黄疸,跌打损伤,烫伤。叶(接骨木叶):苦,凉。活血,行瘀,止痛。用于跌打骨折,风湿痹痛,筋骨疼痛。花(接骨木花):用于发汗,利尿。
栀子(学名:Gardenia jasminoides Ellis)别名:黄栀子、山栀、白蟾,是茜草科植物栀子的果实。栀子的果实是传统中药,属卫生部颁布的第1批药食两用资源,具有护肝、利胆、降压、镇静、止血、消肿等作用。在中医临床常用于治疗黄疸型肝炎、扭挫伤、高血压、糖尿病等症。
具体实施例1
将薄荷1000g、没药1000g、乳香1000g和白芨1000g用蒸馏法汽化成结晶,粉碎待用,为组分1;其他原料木贼1000g,当归1000g,川芎1000g,丹参1000g,决明子1000g,三七1000g,石决明1000g,红花1000g,白芍1000g,夏枯草1000g,紫花地丁1000g,白芷1000g,鸡血藤1000g,栀子1000g,接骨木1000g加水浸泡,加热煮沸3次,每次1-2小时,过滤,滤液备用;将合并后3次的滤液抽入减压浓缩罐内,减压浓缩至相对密度为1.20,温度至60℃-70℃的浸膏;成为组分2,混合组分1和组分2,加防腐剂香料调成眼膜用紫外线灭菌装瓶。
具体实施例2
将薄荷1200g、没药1100g、乳香1200g和白芨1200g用用蒸馏法汽化成结晶,粉碎待用,为组分1;取其他原料木贼1200g,当归1200g,川芎1200g,丹参1200g,决明子1200g,三七1200g,石决明1100g,红花1200g,白芍1200g,夏枯草1100g,紫花地丁1200g,白芷1100g,鸡血藤1200g,栀子1100g,接骨木1100g取其余原料药加入5-10倍量的乙醇中浸泡1-2小时,加热提取2次,每次1-2小时,合并提取液,静置后去上清液,然后100-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.36的浸膏,静置备用,成为组分1。上述乙醇提取过的原料药的药渣加10倍量水,加热回流提取2次,每次1~2小时,将2次提取液合并静置,成为组分2。将组分1和组分2的合并,调和防腐剂制成眼膜,紫外线杀菌后装瓶。
具体实施例3
将薄荷1200g、没药1300g、乳香1200g和白芨1100g用蒸馏法汽化成结晶,粉碎待用,为组分1;取其他原料木贼1200g,当归1200g,川芎1200g,丹参1200g,决明子1200g,三七1200g,石决明1100g,红花1200g,白芍1200g,夏枯草1100g,紫花地丁1200g,白芷1100g,鸡血藤1200g,栀子1100g,接骨木1100g去杂,晾干,粉碎成颗粒,加水浸泡1小时;将浸泡好的原料置多功能提取罐中加水煎煮二次;第一次加总药材10倍量的水,煎煮1.5~2小时,取煎液,滤过;第二次加总量7倍量的水,煎煮1~1.2小时,取两次煎液混合,滤过;将过滤的滤液置入双效真空浓缩器中,浓缩至90℃时相对密度为1.05的浓缩液,置0~5℃低温冷藏24小时;将冷藏液加0.3%的助滤剂硅藻土,过滤,滤液再置入双效真空浓缩器中,浓缩至每1ml含0.1g生药量,直接干燥成粉末后,调和蜂蜜或绿豆粉制成眼膜。
药理学毒性试验
急性毒性实验资料
1、实验方法
将豚鼠背部脊柱两侧将脱毛剂均匀涂上,使去毛范围约40平方厘米。洗净脱毛剂归笼观察24小时,每组豚鼠分别涂本发明中药眼膜0.2、0.4和0.8ml,分别含生药92mg、184mg和368mg),另一组涂溶媒0.8ml每日二次,连续一周,实验结束后,将豚鼠处死,心,肝,肾及脱毛皮肤做病理检验。
2、结果
上述三组用药豚鼠躯干脱毛区,未见局部皮肤有水肿、充血、红斑、出血点及溃疡。用药组豚鼠毛发色泽、摄食、四肢活动等对照组无明显差异,病理组织学检查,给药组心、肝、肾及脱毛皮与对照字比较也无明显差异。
结果提示,本发明中药眼膜无局部刺激作用,也未见全身毒性表现。表明本发明中药眼膜使用安全。
长期毒性实验资料
1、实验方法
将豚鼠随机份成4组,每组15只。在豚鼠背部脊柱两侧将脱毛剂均匀涂上,使其脱毛范围约40平方厘米。洗净脱毛剂,观察24小时后每组豚鼠分别涂本发明眼膜0.2、0.4和0.8ml,分别含生药92、184和368mg),另一组涂溶媒0.8ml每日二次,连续30天,观察豚鼠的一般情况,实验结束后处死动物进行血液学、血液生化及病理学检查。
2、结果
上述三组用药豚鼠躯干去毛区,未见局部皮肤有水肿、充血、红斑、出血点及溃疡。用药组与对照组动物毛发色泽、摄食、四肢活动等对照组无明显差异,血液生化检查,用药组与对照组均在正常范围。病理组织学检查,实验各组心、肝、肾及局部皮肤均未见明显病变。提示,本发明中药眼膜长期用药对局部皮肤及全身重要脏器均未见明显的毒性作用。试验结果表明:本发明中药眼膜实验安全。
药理学实验
一、本发明的微循环实验方法:
1、材料与方法:取50只小鼠,随机分成5组,每组10只(雌雄各半),对照组每鼠右耳涂生理盐水少许;阳性对照组每鼠右耳给予市售新七白美白嫩肤眼膜(上海佰草集化妆品有限公司出品),受试组分为本发明外用眼膜400mg/kg/h。15min后腹腔注射0.1%戊巴比妥钠0.1ml/10g麻醉动物,随后尾静脉注射0.1%肾上腺素0.1mL/10g,立即观察小鼠右耳微动静脉口径(μm)及0.2mm2毛细血管网点数.t检验处理实验数据.
2结果与讨论
2.1.对微循环的影响
与对照组相比,受试组1对小鼠毛细血管开放数有明显增多(P<0.01);受试组2对微静脉口径和毛细血管开放数有显著增加(P<0.01);受试组3对小鼠微动、静脉口径及毛细血管开放数皆有增加(P<0.01);说明受试药能改善微循环,有活血化瘀作用(表1)。
表1、本发明眼膜对小鼠微动、静脉口径及毛细血管开放数的影响
二、对巴豆油所致小鼠耳廓肿胀的影响
取健康小鼠30只,随机分成3组,即空白对照组、新七白美白嫩肤眼膜阳性对照组、本发明眼膜组,每组10只,雌雄各半,阳性对照组和本发明组分别涂抹,空白对照组涂抹等剂量的生理盐水,连续给药7天,于末次给药后0.5小时,在小鼠左耳内外测涂巴豆油致炎剂(2%巴豆油,20%无水乙醇,5%蒸馏水,73%乙醚)0.1ml致炎,致炎后4小时用打孔器(孔径6mm)打下左、右耳片,称重,以左右耳片重量差作为肿胀程度,结果见表2。
表2 对巴豆油所致小鼠耳廓肿胀的影响(X±SD)
| 组别 | 动物数(只) | 肿胀度(mg) |
| 空白对照组 | 10 | 8.51±1.72 |
| 新七白美白嫩肤眼膜组 | 10 | 5.84±1.48** |
| 本发明眼膜组 | 10 | 4.13±1.38# |
注:与对照组比较:**P<0.01;与阳性对照组比较:#P<0.05;由上表实验结果可以看出,本发明眼膜具有更好的消肿药理作用。
三.对角叉菜胶所致大鼠足跖肿胀的影响
取健康大鼠30只,体重180-220g,随机分成空白对照组、新七白美白嫩肤眼膜阳性对照组、本发明眼膜组。每组10只,雌雄各半,分笼饲养。阳性对照组和本发明药物组分别每日涂抹0.2g,空白对照组给予同剂量的生理盐水涂抹,连续给药7天,于末次给药后30分钟,分别在大鼠右后足跖皮下注射1%角叉菜胶混悬液0.1ml/只致炎,分别于致炎前和致炎后15、30、60、120、240分钟测大鼠右后足跖的周长,并计算肿胀率【肿胀率=(致炎后足跖周长-致炎前足跖周长)/致炎前足跖周长×100%】;结果见表3。
表3 对角叉菜胶所致大鼠足跖肿胀的影响(X±SD)
注:与对照组比较:**P<0.01;与阳性对照组比较:#P<0.05;由上表实验结果可以看出,本发明药物组具有更好的消肿祛瘀的药理作用。
3讨论
中医理论认为大部分黑眼圈的发生与肝肾虚有关,肝肾虚后,肾精不能养肝血,而“肝开窍于目”,最终因精血亏损,表现在双眼上就形成黑眼圈。而现代研究也证实黑眼圈是由于经常熬夜,情绪不稳定,眼部疲劳、衰老,导致静脉血管血流速度过于缓慢,眼部皮肤红血球细胞供氧不足,静脉血管中二氧化碳及代谢废物积累过多,形成慢性缺氧,血液较暗并形成滞留以及造成眼部色素沉着,这与中医理论是相吻合的。
黑眼圈的发生的内因与肝、脾、肾三脏以及气血运行的失常关系密切,因此内治在脏腑多从肝脾肾论治,但也是身体内部平衡失调的外在反映。所以在治疗上要从整体出发,辨证施治。肝脾精血充盈、冲任调畅,则血络自有载药之资。肝主疏泄,能调达气血,舒畅情志。若肝气郁结则气血失和.气滞血瘀.壅滞络脉,上结于面则致面斑。肝主藏血。肝血充和,则体健面润。若肝肾不足,精血亏虚,不能上荣则易生面斑。
黑眼圈形成后应对症下药,请教医生,找出病因,及时治疗;对于精神抑郁形黑眼圈要保持精神愉快,减少精神负担,生活有规律,节制烟酒,保障充足的睡眠,促使气血旺盛,容颜焕发;加强眼部的按摩,改善局部血液循环状态,减少淤血滞留;对于遗传性难治的黑眼圈应以保持眼部皮肤的营养供应为主,如涂含油分、水分充足的眼霜,使眼部皮肤及皮下组织充满活力,淡化黑眼圈。
临床试验
说明:我院于2010年9月-2013年9月,使用自制眼膜治疗黑眼圈110例,疗效显著,现报道如下。
临床资料:黑眼圈人士100例。年龄21~45岁,平均31.5岁;未婚者45例,已婚者55例,已育者71例;病程2个月~8年,平均2.33年;大学生45例,教师、干部、科室人员25例,其他人员30例。自述经常熬夜打游戏45例,遗传35倒,失眠20例,临床分为治疗组50例,对照1组、对照2组各25例。
治疗方法:治疗组采用自制中药眼膜,方用:木贼12g,当归15g,川芎13g,没药11g,丹参12g,决明子13g,三七12g,石决明13g,红花13g,白芍112g,白芨111g,薄荷12g,夏枯草13g,紫花地丁12g,白芷13g,乳香11g,鸡血藤12g,栀子13g,接骨木12g。按实施例1制备成眼膜。
取眼膜对照组1、2组,每组25例,分别使用市售的新七白美白嫩肤眼膜(上海佰草集化妆品有限公司出品)、贝佳斯强效眼膜。
操作过程:进行时人员平卧床上,用3%双氧水清洁面部,用负离子喷雾器喷雾面部,同时配合经络穴位按摩十二法进行面部按摩,眼周局部做重点按摩,时间约20min.后取调成糊状的本发明眼膜,均匀涂于眼皮四周,注意不要弄进眼睛,可适当按摩15-30分钟,用温水洗净后擦干,或直接敷于眼周,用面膜纸盖住,防止蹭脏衣被。每周可敷3次,1个月为1疗程。疗程结束后,每月随访1次,连续随访3个月。对比组按摩后直接用产品贴敷于眼周15-30分钟。治疗期间嘱病人防晒,注意休息,并停用其它眼霜,眼膜。
疗效标准
痊愈:治疗2疗程后,眼周色素消退,疗效维持3个月以上,眼疲劳缓解;有效:眼周色素明显变淡,消退50%以上,病人自觉满意,睡眠质量好;或治疗期间眼周色素消失,但随访中又有复发;无效:眼周色素改变不明显或无变化;或曾消退50%以上,但随访中明显加重,试验人员不满意。
治疗结果:治疗组总有效率与各对照组比较,差别均有显著性(P<0.01),说明自制眼膜疗效明显优于市售眼膜。详见表1
表1 3组疗效对比表
注:与其他各组比较*P<0.01
随访结果随访发现,按摩者强于不按摩的人士。复发后,若继续使用仍然有效。
Claims (10)
1.一种缓解眼疲劳黑眼圈的中药眼膜,其特征在于,所述中药眼膜中各种原料药的重量份数包括:木贼10~20份,当归10~20份,川芎10~20份,没药10~20份,丹参10~20份,决明子10~20份,三七10~20份,石决明10~20份,红花10~20份,白芍10~20份,白芨10~20份,薄荷10~20份,夏枯草10~20份,紫花地丁10~20份,白芷10~20份,乳香10~20份,鸡血藤10~20份,栀子10~20份,接骨木10~20份。
2.根据权利要求1所述缓解眼疲劳黑眼圈的中药眼膜,其特征在于,所述中药眼膜中各种原料药的重量份数包括:木贼10~15份,当归10~15份,川芎10~15份,没药10~15份,丹参10~15份,决明子10~15份,三七10~15份,石决明10~15份,红花10~15份,白芍10~15份,白芨10~20份,薄荷10~20份,夏枯草10~20份,紫花地丁10~20份,白芷10~20份,乳香10~20份,鸡血藤10~20份,栀子10~20份,接骨木10~20份。
3.根据权利要求1所述缓解眼疲劳黑眼圈的中药眼膜,其特征在于,所述中药眼膜中各种原料药的重量份数包括:木贼10~20份,当归10~20份,川芎10~20份,没药10~20份,丹参10~20份,决明子10~20份,三七10~20份,绞股蓝10~20份,红花10~20份,白芍10~20份,白芨10~15份,薄荷10~15份,夏枯草10~15份,紫花地丁10~15份,白芷10~20份,乳香10~20份,鸡血藤10~20份,栀子10~20份,接骨木10~20份。
4.一种如权利要求1~3中任一项所述缓解眼疲劳黑眼圈的中药眼膜的制备方法,其特征在于,所述制备方法包括:
a、取薄荷、没药、乳香和白芨用蒸馏法汽化成结晶,粉碎待用,为组分1;
b、其他原料加乙醇提取2次,浓缩过滤为膏状,为组分2;
c、将上述两种组分合并,消毒后加防腐剂调成糊状眼膜。
5.根据权利要求4所述缓解眼疲劳黑眼圈的中药眼膜的制备方法,其特征在于,所述步骤a中,先将原料药薄荷、没药、乳香和白芨用水蒸气法蒸馏,得到结晶物,然后粉碎,过100-120目筛,作为组分1备用。
6.根据权利要求4所述缓解眼疲劳黑眼圈中药眼膜的制备方法,其特征在于,所述步骤b中,取其他原料药加入5-10倍量的乙醇中浸泡4-6小时,加热提取2次,每次1-2小时,合并提取液,静置后去上清液,然后100-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.36的浸膏,静置备用,成为组分2。
7.根据权利要求4所述缓解眼疲劳黑眼圈的中药眼膜制备方法,其特征在于,所述步骤c中,将蒸馏提取的组分1和乙醇提取的组分2混合,加防腐剂调成眼膜,用紫外线杀菌后装瓶。
8.一种如权利要求1~3中任一项所述缓解眼疲劳黑眼圈的中药眼膜的制备方法,其特征在于,所述制备方法包括:
取薄荷、没药、乳香和白芨用蒸馏法汽化成结晶,粉碎过细筛后待用,为组分1;将其余原料药粉碎成颗粒,加水浸泡2-3小时;将浸泡好的原料药置于多功能提取罐中,加水煎煮二次;第一次加总药量质量的10倍量的水,煎煮1~2小时,取煎液,滤过;第二次加加总药量质量7倍量的水,煎煮1~1.5小时,取两次煎液混合,过滤;将过滤的滤液置入双效真空浓缩器中浓缩冷藏,成组分2;然后混合组分1与组分2,调和防腐剂紫外线杀菌后装瓶。
9.根据权利要求8所述缓解眼疲劳黑眼圈的中药眼膜制备方法,其特征在于,滤液在双效真空浓缩器中浓缩的步骤为,先将滤液浓缩至80℃时相对密度为1.25的浓缩液,置0~5℃低温冷藏24小时;将冷藏液加0.3%的助滤剂硅藻土,过滤,滤液再置入双效真空浓缩器中,浓缩至每1ml含0.1g生药量,成组分2。
10.一种如权利要求1~9中任一项所述缓解眼疲劳黑眼圈的中药眼膜的使用方法,其特征在于,洁面后,将眼膜均匀涂抹于眼周,并用中指指肚在眼周按摩15-30分钟,洗去即可;或用眼膜纸将眼膜涂抹范围盖住,第二天早起洗去。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510409242.0A CN104958235A (zh) | 2015-07-14 | 2015-07-14 | 一种缓解眼疲劳黑眼圈的中药眼膜及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510409242.0A CN104958235A (zh) | 2015-07-14 | 2015-07-14 | 一种缓解眼疲劳黑眼圈的中药眼膜及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104958235A true CN104958235A (zh) | 2015-10-07 |
Family
ID=54212454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510409242.0A Pending CN104958235A (zh) | 2015-07-14 | 2015-07-14 | 一种缓解眼疲劳黑眼圈的中药眼膜及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104958235A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106109331A (zh) * | 2016-08-01 | 2016-11-16 | 广州赛莱拉干细胞科技股份有限公司 | 一种眼膜及其制备方法 |
| CN112353923A (zh) * | 2020-11-02 | 2021-02-12 | 李天生 | 一种外用中药眼药水 |
-
2015
- 2015-07-14 CN CN201510409242.0A patent/CN104958235A/zh active Pending
Non-Patent Citations (1)
| Title |
|---|
| 中华人民共和国卫生部: "《化妆品卫生规范》", 31 January 2007 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106109331A (zh) * | 2016-08-01 | 2016-11-16 | 广州赛莱拉干细胞科技股份有限公司 | 一种眼膜及其制备方法 |
| CN112353923A (zh) * | 2020-11-02 | 2021-02-12 | 李天生 | 一种外用中药眼药水 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103751635A (zh) | 一种治疗黄褐斑的中药面膜及其制备方法 | |
| CN102845571B (zh) | 一种桑叶祛斑养颜茶及其制备方法 | |
| CN105342908A (zh) | 一种缓解皱纹的积雪草中药美容抗皱膏及其制备方法 | |
| CN105496917A (zh) | 一种积雪草抗皱面霜及其制备方法 | |
| CN104666579A (zh) | 一种治疗膝关节滑膜炎的中药组合物及其制备方法 | |
| CN103735835B (zh) | 一种治疗少白头的中药制剂及其制备方法 | |
| CN105267477A (zh) | 一种清肝明目的丹参叶保健茶及其制备方法 | |
| CN105616318A (zh) | 一种抗皱紧肤的积雪草中药面膜及其制备方法 | |
| CN106580838A (zh) | 一种中药美白淡斑精华及其制备方法 | |
| CN104922051A (zh) | 一种缓解眼角皱纹眼袋的中药眼霜及其制备方法 | |
| CN106074959A (zh) | 一种缓解黑眼圈的中药组合物及其制备方法 | |
| CN104473153B (zh) | 一种美容养颜的桑葚口服液及其制备方法 | |
| CN105616317A (zh) | 一种缓解眼部皱纹、眼袋的积雪草眼霜及其制备方法 | |
| CN106667852A (zh) | 一种中药祛痘霜及其制备方法 | |
| CN104958235A (zh) | 一种缓解眼疲劳黑眼圈的中药眼膜及其制备方法 | |
| CN106890120A (zh) | 一种中药美白淡斑乳及其制备方法 | |
| CN106924134A (zh) | 一种中药美白淡斑霜及其制备方法 | |
| CN105342954A (zh) | 一种具有活肤化瘀去黄去斑的中药面膜及其制备方法 | |
| CN105395766A (zh) | 一种防治脱发促进头发再生的中药制剂 | |
| CN104888158A (zh) | 一种提高免疫力的罗布麻叶口服液及其制备方法 | |
| CN105920379A (zh) | 一种缓解眼袋的中药眼霜及其制备方法 | |
| CN105919907A (zh) | 中药眼霜制作方法及其眼霜 | |
| CN104524479B (zh) | 一种治疗经前期综合征的中药组合物及其制备方法 | |
| CN105616984A (zh) | 一种益母草去皱美容膏及其制备方法 | |
| CN105663700A (zh) | 抗皱美容膏制作方法及其美容膏 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151007 |